
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Palatin (NYSE American: PTN) is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system. The melanocortin system is involved in regulating important physiological activities such as food intake and energy balance, desire and arousal, and the resolution of harmful inflammation. We are the first company to obtain FDA approval for a melanocortin based therapeutic, Vyleesi, a treatment for women with hypoactive sexual desire disorder (HSDD). With the successful development of Vyleesi and our extensive experience in the development of melanocortin based therapeutics, we are now focused on developing therapeutics that...
Palatin technologies operates in the Pharmaceutical manufacturing industry.
Palatin technologies's revenue is < 1m
Palatin technologies has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.